MedTrace Logo

Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine

NCT00847418 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2010-12-02

No results posted yet for this study

Summary

The purpose of this study is the determination of blood concentration and the effectiveness of esketamine after nasal application.

Conditions

Interventions

DRUG

esketamine hydrochloride

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Manuel Haschke, MD · Clinical Pharmacology and Toxicology, University Hospital Basel

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Completion
2009-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00847418 on ClinicalTrials.gov